MSHO Featured Corporate Sponsor Assistance Program
That's why we offer the Adaptive Assist program: to help facilitate access to clonoSEQ testing services for patients who could benefit from the clinical insights provided by next-generation measurable residual (MRD) testing.
To visit the Website CLICK HERE
MSHO will profile a different Corporate Sponsor Assistance Program in each Bulletin. To view more Patient Assistance Programs, click here.
Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!